Highlights WuXi AppTec Co., Ltd.

Equities

603259

CNE1000031K4

Biotechnology & Medical Research

End-of-day quote Shanghai S.E. Other stock markets 12/12/2025			5-day change	1st Jan Change
94.05 ^CNY	+0.70%		+4.04%	+70.88%

28/11	Traders Await Fresh Catalysts; Asian Stock Markets Churn	MT
28/11	Nomura Adjusts WuXi AppTec's Price Target to HK$132.8 From HK$130.63, Keeps at Buy	MT

Highlights

Pentagon Cites Eight Chinese Companies for Military Aid	27/11	MT
Wuxi Apptec Looks to Extend CRDMO Platform to Saudi Arabia as It Signs Strategic Mous with Neom and Ministry of Health	28/10	CI
WuXi AppTec Books 53% Higher Profit in Q3; Agrees to Sell Two Units to Hillhouse Investment	27/10	MT
WuXi AppTec Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	26/10	CI
WuXi AppTec's unit plans asset sales	26/10	RE
WuXi AppTec Co., Ltd. Raises Earnings Guidance for They Full Year 2025	26/10	CI
Wuxi Apptec's Q3 net profit up 53.3% Y/Y	26/10	RE
Shandong Buchang Pharmaceuticals Unit Signs 11-Million-Yuan Technical Service Contract	17/10	MT
WuXi AppTec Offloads Further Stake in WuXi XDC Cayman	10/10	MT
Wuxi Apptec signs disposal deal for HK$2.346 billion	09/10	RE
WuXi AppTec Co., Ltd. Implements First Interim Dividend Plan	22/09	CI
China Healthcare Sector's Fundraising Expected to Reach Record in 2025, Analysts Say	10/09	MT
Tranche Update on WuXi AppTec Co., Ltd.'s Equity Buyback Plan announced on March 17, 2025.	27/08	CI
WuXi AppTec Co., Ltd.'s Equity Buyback announced on March 17, 2025, has closed with 11,860,809 shares, representing 0.35% for CNY 1,000 million.	26/08	CI
China's Wuxi Apptec to raise $980 million via new shares to boost expansion	31/07	RE
WuXi AppTec Plans to Raise $975 Million Via Share Placement	31/07	DJ
Wuxi Apptec to raise price cap for A-share buyback	29/07	RE
WuXi AppTec Shares Rise After Raising Full-Year Guidance	29/07	DJ
Tranche Update on WuXi AppTec Co., Ltd.'s Equity Buyback Plan announced on March 17, 2025.	28/07	CI
WuXi AppTec's H1 Profit Surges 96%	28/07	MT
WuXi AppTec Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	28/07	CI
Wuxi Apptec Co., Ltd. Announces First Interim Dividend for Period Ended 30 June 2025, Payable on 26 September 2025	28/07	CI
Wuxi AppTec Co., Ltd. Provides Earnings Guidance for the Year 2025	28/07	CI
Wuxi Apptec's H1 net profit up 101.9% Y/Y	28/07	RE
Solvonis Therapeutics plc Announces the Initiation of Key Translational Studies to Support the Advancement of SVN-002 Towards A Planned Phase 2B Clinical Trial in the United States	22/07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights WuXi AppTec Co., Ltd.

Equities

603259

CNE1000031K4

Biotechnology & Medical Research

Highlights

Filters